I agree that this site is using cookies. You can find further informations here.
X
Yokoyama, Toshihide
45  results:
OpenAccess-fulltext X
Search for persons X
?
1

Incidence and impact of interstitial lung disease and malig..:

Ikeda, Satoshi ; Arita, Machiko ; Misaki, Kenta...
http://www.springerplus.com/content/4/1/240.  , 2015
Link: http://www.springerplus...
 
?
2

Randomized, open-label phase II study of brigatinib and car..:

Kazushige Wakuda ; Hirotsugu Kenmotsu ; Yuki Sato...
https://doi.org/10.1186/s12885-023-11417-w.  , 2023
Link: https://doi.org/10.1186/..
 
?
3

Pneumonitis associated with pembrolizumab plus chemotherapy..:

Daichi Fujimoto ; Satoru Miura ; Keisuke Tomii...
https://doi.org/10.1038/s41598-023-30676-y.  , 2023
Link: https://doi.org/10.1038/..
 
?
4

Exploratory analysis of immunochemotherapy compared to chem..:

Tae Hata ; Chikara Sakaguchi ; Keita Hirano...
https://doi.org/10.1111/1759-7714.14836.  , 2023
Link: https://doi.org/10.1111/..
 
?
5

Liquid biopsy detects genomic drivers in NSCLC without EGFR..:

Takehiro Uemura ; Hirotsugu Kenmotsu ; Daisuke Hazama...
https://doi.org/10.1002/cam4.6668.  , 2023
Link: https://doi.org/10.1002/..
 
?
6

Real-World Treatments and Clinical Outcomes in Advanced NSC..:

Hiroshi Nokihara ; Takashi Kijima ; Toshihide Yokoyama...
Cancer Therapy.  , 2022
Link: https://doi.org/10.3390/..
 
?
7

Prospective analysis of factors precluding the initiation o..:

Shigeru Tanzawa ; Tomonori Makiguchi ; Sadatomo Tasaka...
https://doi.org/10.1177/17588359221116603.  , 2022
Link: https://doi.org/10.1177/..
 
?
8

A new risk-assessment tool for venous thromboembolism in ad..:

Yukari Tsubata ; Takamasa Hotta ; Kosuke Hamai...
https://doi.org/10.1186/s13045-022-01259-7.  , 2022
Link: https://doi.org/10.1186/..
 
?
9

Hypothyroidism as an immune-related adverse event caused by..:

Masanori Kawataki ; Yosuke Nakanishi ; Toshihide Yokoyama.
http://www.sciencedirect.com/science/article/pii/S2213007122000077.  , 2022
Link: https://doi.org/10.1016/..
 
?
10

The Effect of Pleural Effusion on Prognosis in Patients wit..:

Tomoka Nishimura ; Eiki Ichihara ; Toshihide Yokoyama...
https://www.mdpi.com/2072-6694/14/24/6184.  , 2022
Link: https://doi.org/10.3390/..
 
?
11

Real-World Treatments and Clinical Outcomes in Advanced NSC..:

Hiroshi Nokihara ; Takashi Kijima ; Toshihide Yokoyama...
https://www.mdpi.com/2072-6694/14/12/2846.  , 2022
Link: https://doi.org/10.3390/..
 
?
12

Incidence of venous thromboembolism in advanced lung cancer..:

Yukari Tsubata ; Takamasa Hotta ; Kosuke Hamai...
https://doi.org/10.1177/17588359221110171.  , 2022
Link: https://doi.org/10.1177/..
 
?
13

The Effect of Pleural Effusion on Prognosis in Patients wit..:

Tomoka Nishimura ; Eiki Ichihara ; Toshihide Yokoyama...
Cancer Immunology and Immunotherapy.  , 2022
Link: https://doi.org/10.3390/..
 
?
14

Clinical factors associated with shorter durable response, ..:

Kazutaka Hosoya ; Daichi Fujimoto ; Takeshi Morimoto...
https://doi.org/10.1186/s12885-021-08048-4.  , 2021
Link: https://doi.org/10.1186/..
 
?
15

Crizotinib for recurring non‐small‐cell lung cancer with EM..:

Daijiro Harada ; Hideko Isozaki ; Toshiyuki Kozuki...
https://doi.org/10.1111/1759-7714.13825.  , 2021
Link: https://doi.org/10.1111/..
 
1-15